Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity by Giraldo, Patricia et al.
Functional dissection of the mouse tyrosinase locus
control region identi®es a new putative boundary
activity
Patricia Giraldo1, Antonio MartõÂnez2, LucõÂa Regales1, Alfonso Lavado1,
Angel GarcõÂa-DõÂaz1, AÂ ngel Alonso3, Ana Busturia2 and LluõÂs Montoliu1,*
1Department of Molecular and Cellular Biology, Centro Nacional de BiotecnologõÂa (CNB-CSIC), Campus de
Cantoblanco, 28049 Madrid, Spain, 2Centro de BiologõÂa Molecular `Severo Ochoa' CBM-CSIC/UAM, Campus de
Cantoblanco, 28049 Madrid, Spain and 3Deutsches Krebsforschungszentrum, Themenbereich Infektion und Krebs,
Im Neuenheimer Feld, 280, D-69120 Heidelberg, Germany
Received June 26, 2003; Revised July 26, 2003; Accepted August 27, 2003 DDBJ/EMBL/GenBank accession nos X76647, AF364302
ABSTRACT
Locus control regions (LCRs) are complex high-
order chromatin structures harbouring several
regulatory elements, including enhancers and
boundaries. We have analysed the mouse tyro-
sinase LCR functions, in vitro, in cell lines and,
in vivo, in transgenic mice and ¯ies. The LCR-core
(2.1 kb), located at ±15 kb and carrying a previously
described tissue-speci®c DNase I hypersensitive
site, operates as a transcriptional enhancer that
ef®ciently transactivates heterologous promoters
in a cell-speci®c orientation-independent manner.
Furthermore, we have investigated the boundary
activity of these sequences in transgenic animals
and cells. In mice, the LCR fragment (3.7 kb) res-
cued a weakly expressed reference construct that
displays position effects. In Drosophila, the LCR
fragment and its core insulated the expression of a
white minigene reporter construct from chromo-
somal position effects. In cells, sequences located
5¢ from the LCR-core displayed putative boundary
activities. We have obtained genomic sequences
surrounding the LCR fragment and found a LINE1
repeated element at 5¢. In B16 melanoma and L929
®broblast mouse cells, this element was found
heavily methylated, supporting the existence of
putative boundary elements that could prevent the
spreading of condensed chromatin from the LINE1
sequences into the LCR fragment, experimentally
shown to be in an open chromatin structure.
INTRODUCTION
Eukaryotic genes are generally organised on chromosomes as
contiguous but independent units known as expression
domains (1,2). Usually, they are represented as chromatin
®bres in the form of loops whose ends remain attached to
nuclear matrix or scaffold components, thereby preventing the
interference between adjacent expression domains (3,4).
These expression domains are believed to remain insulated
from neighbouring genomic sequences by boundary elements
(5), and are thought to include all regulatory elements that are
necessary for their proper gene expression (6).
We use the mouse tyrosinase locus as an experimental
model to study mammalian expression domains in transgenic
animals (7). The mouse tyrosinase gene, located on chromo-
some 7, encodes the rate-limiting enzyme for melanin
biosynthesis and is tightly regulated during development. It
is expressed from embryonic day +16.5 in melanocytes,
derived from neural crest, and from day +10.5 in RPE cells,
derived from the optic cup (8). Minigene tyrosinase constructs
were used in mice to rescue the albino phenotype of recipient
animals (8,9). These transgenic mice often displayed position
effects, manifested as variability in pigmentation levels and
variegation (10).
In contrast, the generation of transgenic mice with yeast
arti®cial chromosome (YAC) constructs covering 250 kb of
the mouse tyrosinase locus completely rescued the albino
phenotype (11), reviewed in (10). These results suggested the
existence of important regulatory elements, absent in previous
standard constructs, which allow YAC tyrosinase transgenes
to overcome position effects (12). One of these elements was
identi®ed during the molecular characterisation of the
chinchilla-mottled allele (Tyrc±m), and was found ~15 kb
upstream of the tyrosinase gene (13). It contains a DNase I
hypersensitive site (HS) that functions as a cell-speci®c
enhancer in vitro and in vivo, when combined with the
endogenous tyrosinase promoter (14±16). The relevance of
this element was evaluated in vivo by generating deletions
within YAC tyrosinase transgenes that allowed the description
of a novel locus control region (LCR) in the mouse tyrosinase
gene (14,17). The albino phenotype was totally rescued in the
presence of the LCR. The absence of the LCR resulted in
weaker pigmentation, variegated expression in all cellular
types known to express the tyrosinase gene and delayed retinal
pigmentation in transgenic mice (18).
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LCRs are de®ned functionally, as they share little, if any,
sequence or structural homology. They can overcome position
effects in transgenesis, with an expression value per copy
comparable with the endogenous alleles (19,20). LCRs are
complex high-order chromatin structures containing regula-
tory sequences that can incorporate several activities, includ-
ing transcriptional enhancers (20), scaffold/matrix attachment
regions (S/MARs) (6) and boundary elements (5). To date, the
best-known LCR is that of the human b-globin locus (21). The
function of this LCR has been extensively studied in
transgenic analyses (19) and at its endogenous genomic site
(22,23).
Insulator or boundary elements were ®rst characterised in
Drosophila melanogaster and yeast genomes and subse-
quently found in a number of vertebrates (including chicken,
mouse and human genome) and other organisms (5,24±26).
Boundaries have been de®ned functionally by at least one of
the following two properties. First, they have a barrier activity,
protecting a gene against chromosomal position effects (27),
such as the spreading of chromatin condensation and
heterochromatinisation into expression domains, as seen in
¯ies (28,29), mammalian cells (30) and yeast (31). Secondly,
insulators can also have a blocker activity interfering with the
transactivation of a given promoter by a distal enhancer when
placed between these two regulatory elements. This has been
studied best in the Drosophila boundary elements, such as the
scs/scs' sequences from the hsp70 loci (32) and the Su(Hw)
binding region of the gypsy element (33±35).
A few boundary elements have been shown to display both
features. This is the case of the best-known insulator in
vertebrates, present at the 5¢HS4 element of the chicken
b-globin locus (36,37), which acts as a blocker, insulating
from the activity of enhancers located in the 5¢ upstream folate
receptor gene (38), and as a barrier, preventing silencing from
an upstream region of condensed chromatin (39). These two
features appear to be transduced by separate protein activities
(40). Analogous insulator elements appear to be present in the
homologous human and mouse b-globin loci (41).
Some boundaries have been tested in heterologous systems
for gene transfer applications, although with limited success
(42±44). Little is known about the molecular mechanisms
underlying insulator function for which several models have
been proposed (5,45,46). Further in vivo studies in their
natural genomic context will be required to help understand
the function of boundary elements in ectopic locations.
Here, we have evaluated, in vitro and in vivo, the enhancer
and boundary activities of the 3.7 kb EcoRI fragment that
contains the mouse tyrosinase LCR. We describe that
enhancer functions are operative in front of heterologous
promoters in a cell type-dependent and orientation-independ-
ent manner. We have discovered a new boundary activity in
this region, using transgenic mice and ¯ies. In mice, we show
that the LCR fragment can rescue the expression of a
luciferase reporter transgene prone to position effects. In
Drosophila, we have used the standard white minigene assay,
with appropriate positive and negative controls, to show that
mouse tyrosinase LCR sequences ef®ciently protect this
reference construct from chromosomal position effects.
Further, we have obtained genomic sequences surrounding
this LCR and identi®ed a LINE1 (Long Interspersed
Elements) repeated element located 5¢ upstream from the
LCR fragment. We show that this repeated element is
methylated in both tyrosinase-expressing and non-expressing
cells. The chromatin spanning over the LCR appears more
accessible to DNase I digestion in tyrosinase-expressing cells.
Finally, results obtained from in vitro enhancer-blocking tests
further support the presence of putative boundary elements
within this LCR fragment. These elements might contribute to
the LCR function by preventing the spreading of condensed
chromatin, presumably formed on the upstream LINE1
methylated sequences, thus possibly establishing the putative
5¢ boundary of the mouse tyrosinase expression domain.
MATERIALS AND METHODS
Description of plasmids
Fire¯y luciferase gene was obtained from plasmid pDO432
(47) as a 1.8 kb SspI±BamHI fragment and cloned into
pW37SP1 vector (4 kb) (48) resulting in plasmid pTLuc
(5.75 kb). pW37SP1 contains a TATA box from the promoter
of the herpes simplex virus thymidine kinase (HSV-TK) gene
(±37/+19) next to two binding sites for the ubiquitous
transcription factor SP1, and the splice site and polyadenyla-
tion signal from SV40 small-t antigen. pTKLuc (5.8 kb)
contains the promoter of the HSV-TK gene (±105/+51) from
pBLCAT2 (49). pTyrLuc (5.9 kb) contains the mouse
tyrosinase promoter (±270/+9) from pCAT (14). The HS
(2.13 kb) and X (2.4 kb) regions are derived from plasmid
pTyr14:E6 (14) and were cloned, in either direction, in pTLuc,
pTKLuc and pTyrLuc vectors, resulting in pHSTLuc/
pSHTLuc (7.87 kb), pXTLuc/pXinvTLuc (8.14 kb),
pHSTKLuc/pSHTKLuc (7.93 kb), pXTKLuc/pXinvTKLuc
(8.2 kb), pHSTyrLuc/pSHTyrLuc (8.03 kb) and pXTyrLuc/
pXinvTyrLuc (8.3 kb) constructs. pHSDATluc (7.85 kb),
pHSDBTluc (7.85 kb) and pHSDABTLuc (7.81 kb) deletion
constructs were derived from pHSTLuc with the following
deletions: (nucleotide positions are given with respect to
X76647): DA, nucleotides 2622±2654; DB, nucleotides
2657±2682; and DAB, nucleotides 2622±2682 (50) (see
Supplementary Material). In addition, the LCR fragment
(3.71 kb), entirely contained in plasmid pTyr14:E6 (14) and
the LCR fragment carrying the DAB deletion (described
above) and/or a deletion of a G-rich box (DG; X76647,
nucleotides 1±71) were cloned, in either direction, in
pTKLuc vector, resulting in pLCRTKLuc/pRCLTKLuc
(9.51 kb), pLCRDGTKLuc/pRCLDGTKLuc (9.45 kb),
pLCRDABTKLuc/pRCLDABTKLuc (9.44 kb) and pLCRD-
ABGTKLuc/pRCLDABGTKLuc (9.38 kb) constructs,
respectively.
For the generation of transgenic ¯ies the reference plasmid
was pCaSpeR3 (referred in this work as w, 7.8 kb), carrying
the white minigene (51). BRwBR plasmid (8.8 kb) was used as
reported (52). The rest of the constructs used in ¯ies were
derived from pCaSpeRW15* (7.8 kb), a modi®ed version of
pCaSpeRW15 (52) with an additional EcoRI site, at the 3¢ end
of the white minigene. LCR, HS, X, LCRmut, TE3 and 5¢HS4
fragments were cloned at either side of pCaSpeRW15*
resulting in LCRwLCR (15.2 kb), HSwHS (12 kb), XwX
(12.4 kb), LCRmutwLCRmut (15.1 kb), TE3wTE3 (11.2 kb)
and 5¢HS4w5¢HS4 (12.6 kb) constructs, respectively. The
5¢HS4 insulator fragment was obtained from pBC1 plasmid
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(Invitrogen), as a 2.4 kb XbaI fragment containing two copies
in tandem of the 1.2 kb 5¢HS4 from the chicken b-globin locus
(36). The TE3 fragment was obtained from pgTYR-H1.8A as
a 1.7 kb HindIII fragment (53).
Plasmid DNAs were puri®ed, using Qiagen Plasmid Maxi
Kit (Qiagen) or Concert High Purity Maxiprep Plasmid
System (Gibco-BRL, Life Technologies). All plasmids were
con®rmed by restriction enzyme and sequence analyses.
Detailed description of plasmids is available upon request.
Culture and transient transfections of mammalian cells
B16 mouse melanoma, MeWo human melanoma, L929 mouse
®broblasts and D407 human RPE cells (54) were grown as
described (14). PC12 rat phaeochromocytoma cells were
grown in RPMI medium, supplemented with 10% horse serum
(Life Technologies), 5% fetal calf serum and 1 mM sodium
pyruvate. All cells included 2 mM glutamine, 103 U/ml
penicillin, 1 mg/ml streptomycin and 10 mM HEPES pH 7.4
and were incubated at +37°C, 5% CO2 and 98% humidity.
Transient transfection assays were carried out, in triplicates,
using TransFast (Promega), according to the supplier. For
each transfection experiment 2.5 mg of experimental
Luciferase reporter construct along with 0.5 mg of pCMV-
lacZ control plasmid were co-transfected. Luciferase assays
were performed using commercial systems (Promega) and
measured in a microplate luminometer (Microlumat Plus,
EG&G Berthold). b-Galactosidase activity was determined
using published procedures (14). Statistical evaluation of
transfection data, when indicated, was performed by t-Student
paired test (SPSS).
Generation and analysis of transgenic ¯ies
Transgenic ¯ies (D.melanogaster) were made following
standard procedures (55), using w1118 or Df ac1 w1118 mutant
embryos as hosts (Bloomington Stock Centre, Indiana
University, USA). Chromosomal localisation of the insertion
was determined by crossing transgenic males with w1118; If/
CyO; TM2/MKRS females (56). Copy number was con®rmed
by Southern blot analysis, using two probes (white and
P-element) derived from plasmid pCaSpeRW15. Eye pig-
mentation was noted in 30±70 homozygous and heterozygous
72 h female ¯ies from each transgenic line. In total, more than
10 000 transgenic ¯ies were generated and observed.
However, only single-copy transgenic lines that could be
established in heterozygosis and homozygosis, corresponding
to 3059 and 3060 individuals, respectively, were used for
graphical and statistical analyses. Eye colour was assigned to
one of the following ®ve categories: yellow, pale orange,
orange, brown and red (Fig. 4). For graphical purpose, the
amount of red pigment in eyes was measured as described
(57). Statistical analysis of transgenic ¯y data was done using
SPSS.
Generation and analysis of transgenic mice
Transgenic mice were generated using standard procedures
(58) using albino recipient mouse strains NMRI or FVB/N
(Harlan), as reported before (17). Transgenic founder mice
were identi®ed by PCR and Southern blot analyses.
Transgenic lines were established and their copy number
evaluated in F1 heterozygous individuals by slot-blot analysis
(59). All experiments complied with local and European
legislation concerning vivisection and the experimentation
and use of genetically modi®ed organisms.
To evaluate luciferase activity in mice, six adult (2±3
months of age) hemizygous individuals were analysed from
each transgenic line. Protein extracts were prepared from nine
organs (dorsal skin, eyes, skeletal muscle, thin gut, kidney,
spleen, liver, lung and brain) in cell culture lysis buffer
(Promega), following supplier indications. Protein contents
were evaluated using Bio-Rad Protein Assay (Bio-Rad).
Luciferase assays were performed as described in cell
transfection assays. A series of dilutions were assayed from
each extract to ensure that measured values were not
quenched.
Isolation of a genomic clone containing LCR and
surrounding sequences
A 129Sv/J mouse genomic library (Stratagene) was screened
with a single-copy DNA probe (probe A, 0.9 kb XbaI fragment
from pTyr14:E6, shown in Fig. 5) using standard methods
(59). Eighteen independent bacteriophage clones were iden-
ti®ed, four of which were subjected to three consecutive
rounds of screening. One of these clones, lT1, contained a
14 kb insert that included the LCR, was mobilised into a
plasmid, pN14n21, and entirely sequenced in both senses of
the DNA using speci®c oligonucleotides (more than 60) and
subclones of internal DNA fragments. Details are available
upon request.
DNA methylation analysis
Ten micrograms of HindIII digested genomic DNAs from B16
or L929 cells were denatured and treated with sodium
bisulphite. Puri®cation and ampli®cation of transformed
DNA was performed essentially as reported (60). Oligo-
nucleotides BIS1A (5¢-ATATaAaaACaTACATATAaCAC-
CCC-3¢; AF364302, nucleotides 5304±5279) and BIS2 (5¢-
GTGTTttAtTtAttAGAGATtTTAGGG-3¢; AF364302, nu-
cleotides 4741±4767) were ®rst used to amplify a 563 bp
DNA band [PCR conditions: AmpliTaq (Roche), 10 cycles:
2 min at 94°C, 15 s at 55°C and 4 min at 68°C; followed by
25 cycles: 15 s at 94°C, 15 s at 55°C and 3 min at 68°C,
increasing by 20 s the extension step at 68°C in each cycle].
Thereafter, oligonucleotides BIS2 and BIS1B (5¢-
CCAaaaAATTCCTaAAaCTaATaACC-3¢; AF364302, nu-
cleotides 5268±5243) were used for a second round of nested
ampli®cation using the same PCR conditions and resulting in a
527 bp DNA band. Transformed nucleotides are written in
lowercase. The ampli®ed DNA fragment, from several pooled
PCR ampli®cations, was cloned directly into pCRII
(Invitrogen). Four (B16 DNA) and ®ve (L929 DNA)
independent clones were sequenced entirely from either
direction. A consensus sequence was derived after multiple
alignment of individual DNA sequences with the original
reference genomic sequence (527 bp; AF364302, nucleotides
4741±5268) using MacVector (Accelrys).
DNAse I sensitivity assays
DNase I sensitivity analysis was performed essentially as
described (61). In brief, nuclei were isolated from B16 and
L929 cells following described procedures (62), and digested
for 10 min at 37°C with increasing amounts of DNase I DPFF
(Worthington) (in the range between 0 and 200 U/ml).
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Following proteinase K digestion, DNA samples were puri®ed
by phenol extraction and ethanol precipitation. Fifteen
micrograms of each DNA sample, in triplicates, were
vacuum-loaded onto a nylon membrane (Hybond-N,
Amersham) using a slot-blot apparatus (Minifold II,
Schleicher & Schuell). Membranes were hybridised with E3,
A, B, C, D, E5 and PGK ramdom prime [a-32P]dCTP-labelled
DNA probes (shown in Fig. 5), following standard methods
(59). E3, A, B, C, D, E5 and PGK DNA probes were
experimentally validated as single-copy probes by standard
Southern blot analysis on mouse genomic DNA. Hybridisation
signals were quantitated using a PhosphorImager (Molecular
Dynamics, Inc.) and analysed using ImageQuant software.
DNA sequences
DNA sequences referred to in this work have been submitted
to GenBank and EMBL Databases under accession numbers
X76647 and AF364302, respectively. X76647 DNA sequence
is included within AF364302 sequence.
RESULTS
Analysis of LCR function: enhancer activity with
heterologous promoters in mammalian cells
To functionally dissect the mouse tyrosinase LCR and to
understand its fundamental role in the regulation of this locus
we sequenced the entire 3.7 kb EcoRI DNA fragment that
contained the LCR, extending previously available informa-
tion. Several internal DNA constructs were prepared and
analysed in vitro and in vivo (Fig. 1).
To evaluate in vitro transcriptional transactivation capaci-
ties of mouse tyrosinase LCR sequences in front of
heterologous promoters, we made three types of luciferase
reporter plasmids. These were driven by a minimal synthetic
promoter formed by a TATA box from the HSV-TK gene and
two binding sites for the ubiquitous transcription factor Sp1
(48), or the HSV-TK gene promoter (49) (pTLuc and pTKLuc
constructs; Fig. 1B). We incorporated the endogenous mouse
tyrosinase promoter as a control (pTyrLuc constructs; Fig. 1B),
as reported previously (14).
All these constructs were transiently transfected in cell
types that potentially express the tyrosinase gene (mouse B16
melanoma, human MeWo melanoma and human D407 RPE
cells) and cells that do not express the tyrosinase gene (i.e. rat
PC12 phaeochromocytoma cells). Although tyrosinase gene is
expressed, in vivo, in RPE cells (8), immortalised RPE cells
(such D407) normally lose their capacity to express tyrosinase
Figure 1. DNA constructs used for in vitro and in vivo assays.
(A) Schematic view of the mouse tyrosinase locus and LCR sequences in
mouse chromosome 7. A bent arrow indicates the transcription start site and
direction of the mouse tyrosinase gene. Exons (5) are indicated as black
rectangles. Not drawn to scale. A 1.7 kb fragment containing mouse
tyrosinase exon 3 (TE3) and surrounding intronic sequences is shown below
the mouse tyrosinase gene. The 3.7 kb EcoRI fragment containing the
mouse tyrosinase LCR, located at ±15 kb of the gene is shown below (3711
bp, EMBL Database X76647). Relative position of the 3.7 kb EcoRI DNA
fragment with respect to the start of transcription of the tyrosinase gene
(±15 kb) has been updated, according to the latest available mouse genome
sequence information (see legend for Fig. 5), therefore correcting the
position assigned to this LCR fragment in previous reports (14,17). The
relative position of restriction enzymes used to subclone internal fragments
is indicated along with their size in base pairs (bp). A and B black boxes,
referred to previously as HS-1 and HS-2 (14), identify binding sequences
for nuclear factors. (B) Three series of backbone plasmids are shown:
pTLuc, containing a TATA box from the HSV-TK gene (white box), linked
to two sites for the ubiquitous transcription factor Sp1 (white ovals);
pTKLuc, containing the promoter of the HSV-TK gene (grey box); and
pTyrLuc, carrying the mouse tyrosinase promoter (black box). Upstream of
each promoter, the HS and X fragments were cloned in either direction
(depicted as two arrows) resulting in the plasmids pHSTLuc, pSHTluc,
pXTLuc, pXinvTLuc, pHSTKLuc, pSHTKLuc, pXTKLuc, pXinvTKLuc,
pHSTyrLuc, pSHTyrLuc, pXTyrLuc and pXinvTyrLuc, respectively.
(C) Plasmids used for functional analysis of deletion mutants within the HS
fragment. (D) Constructs used to evaluate boundary activities of mouse
tyrosinase LCR sequences in transgenic mice. All constructs shown in
(B), (C) and (D) share the ®re¯y luciferase reporter gene and the 3¢ splice
site and polyadenylation signal from the small t gene of the SV40 genome,
indicated as pA. (E) DNA constructs used to evaluate boundary activities of
mouse tyrosinase LCR sequences in transgenic ¯ies. `w' represents the
reference construct [pCaSpeR3 (51)] containing a white minigene
surrounded by 3¢P and 5¢P sequences from a P element (shown as triangles
in a box). BRwBR carries the Su(Hw) BR of gypsy retrotransposon (52),
5¢HS4w5¢HS4 carries two copies of the 1.2 kb fragment containing the
5¢HS4 of the chicken b-globin locus (36), TE3wTE3, HSwHS, XwX,
LCRwLCR and LCRmutwLCRmut contain the corresponding mouse
tyrosinase LCR DNA fragments.
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in most culture conditions and hence, melanin synthesis ceases
(54,63).
In the presence of a fragment containing the LCR-core
indicated as a putative DNase I tissue-speci®c HS and two
putative binding sites (boxes A and B) for nuclear factors (HS
DNA fragment; Fig. 1A) (14), transcriptional enhancement
was observed in B16 and MeWo cells, irrespective of the
promoter used, and with similar relative transactivation values
(Fig. 2A and B). Sequence inspection of A and B boxes had
shown the existence of target sequences similar to DNA-
binding motifs for the ubiquitous transcription factors CREB
(cAMP responsive element binding) and AP-1 (activator
protein 1) (14). In D407 cells, transfected constructs with the
tyrosinase promoter do not appear to function, in agreement
with the endogenous tyrosinase gene being silent (54,63).
However, in these cells, heterologous promoters are also
capable of being speci®cally transactivated by the HS DNA
fragment, although with lower transactivation values (Fig. 2C),
suggesting that cell type-speci®c trans-acting nuclear factors
or tissue-speci®c modi®cations of ubiquitous factors that
normally bind the HS DNA fragment operate irrespective of
the activity of its corresponding tyrosinase promoter.
In contrast, transcriptional enhancer function of HS was not
found in PC12 cells (Fig. 2D). Absence of HS enhancer
function was also observed in other cell types tested that do
not express the tyrosinase gene such as rat FTO-2B hepatoma,
mouse NIH3T3 ®broblasts, mouse L929 ®broblasts, Chinese
hamster ovary and human Weri-Rb retinoblastoma cells (not
shown), supporting that cell-speci®c nuclear factors or tissue-
speci®c modi®cations of ubiquitous factors, presumably
binding to box A and box B (14), are required to mediate
heterologous transactivation by the HS fragment.
Cell-speci®c enhancer function associated with the HS
fragment was shown to operate irrespective of its orientation
with comparable induction values, both in combination with
homologous (tyrosinase) and heterologous promoters
(Fig. 2E). No signi®cant response was seen with the X
fragment (Fig. 1A) with heterologous or homologous pro-
moters (Figs 1B and 2), in either orientation (not shown).
The speci®c contributions of box A and box B to the
enhancer function of the HS fragment was assayed in B16
cells using a heterologous promoter (pTLuc constructs)
(Fig. 1C). The presence of both the A and the B boxes is
required to activate transcription on heterologous promoters
(Fig. 2F), suggesting a pivotal role of both cis-regulatory
sequences in the tissue-speci®c enhancer function of the HS
fragment. Similar behaviour was observed previously using
homologous promoter sequences (14).
Analysis of LCR function: boundary activity measured
as protection from chromosomal position effects in
transgenic mice
Previous analyses with standard and arti®cial-chromosome
type constructs in transgenic mice suggested the existence,
within the LCR fragment, of a putative boundary activity that
could overcome chromosomal position effects. This activity
was primarily associated with the tissue-speci®c enhancer
function mapping within the mouse tyrosinase LCR (10,17).
The results that we obtained using the HS DNA fragment in
combination with heterologous promoters in transiently
transfected cells (Fig. 2) prompted us to evaluate these
constructs in vivo, in transgenic animals, in an attempt to
distinguish between tissue-speci®c enhancer mediated and
boundary effects.
In order to evaluate this boundary function, we analysed
whether the HS or the LCR fragments could rescue the weak
and variable expression of a reporter transgene driven by a
minimal synthetic promoter, prone to position effects (pTLuc,
Fig. 1D). In this context, the `LCR fragment' refers to the
3.7 kb EcoRI DNA fragment initially shown to contain a
tissue-speci®c DNase I HS (14), conferring copy number-
related expression of tyrosinase minigenes in transgenic mice
(14) and later shown to contain a proper LCR activity upon
functional analysis of YAC tyrosinase-deletion derivatives in
Figure 2. Evaluation of the enhancer function of LCR sequences with
homologous and heterologous promoters by transient transfection analysis
in mammalian cells. Transient transfections of MeWo (A), B16 (B, E and
F), D407 (C) and PC12 (D) cells, using HS, SH, X, HSDA (DA), HSDB
(DB), HSDAB (DAB) or none (±) LCR-derived fragments in combination
with pTLuc (white bars), pTKLuc (grey bars) heterologous promoters and
pTyrLuc (black bars) homologous promoter backbone plasmids (Fig. 1).
Results are expressed as relative transactivation, arbitrarily assigning to
backbone promoter-only plasmids (pTLuc, pTKLuc and pTyrLuc,
respectively) the value of x1 and thereafter referring the activity of each
construct to its corresponding promoter-only plasmid. In PC12 and D407
cells, tyrosinase promoter constructs produced luciferase reporter expression
values close to background. Normalisation of the luciferase reporter values
between different transfected constructs is achieved taking into account the
activity of a co-transfected lacZ reporter plasmid and the number of pmols
of experimental plasmid DNA used in each transfection. See Materials and
Methods for plasmid sizes. Relative transactivations are mean values from
triplicate experiments (6SD).
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transgenic mice (17). We prepared two additional constructs
from pTLuc with the HS (pHSTLuc) or the LCR (pLCRTLuc)
fragments cloned 5¢ upstream of the minimal promoter
(Fig. 1D). We included the putative boundary element (HS
or LCR) only at one end (5¢) of the constructs because, in
standard mouse transgenesis, constructs usually integrate as
multicopy tandem arrays. Therefore, most transgene copies
would end up shielded by putative boundary elements at either
side.
We generated ®ve independent lines of transgenic mice for
pTLuc, as well as ®ve for pHSTLuc and eight for pLCRTLuc
heterologous constructs. Luciferase activity was measured in a
number of organs from adult F1 and F2 individuals of all these
transgenic lines. Results from transgenic mouse lines in which
luciferase expression could be detected are shown in Figure 3,
along with the corresponding transgene copy number for each
line. Four out of ®ve pTLuc transgenic mouse lines showed
very low but detectable luciferase expression, in at least one
tissue (lines 1A to 1D, Fig. 3). In the ®fth pTLuc transgenic
line (1E, ®ve copies) we could not detect luciferase expression
(not shown). These results obtained with pTLuc indicated that
this transgene is quite sensitive to chromosomal position
effects.
Three out of ®ve pHSTLuc transgenic mouse lines showed
luciferase expression at variable levels. Two pHSTLuc lines
(lines 2A and 2C, Fig. 3) showed higher luciferase expression
levels than those obtained with pTLuc, whereas a third line
(line 2B, Fig. 3) behaved similarly. In the two remaining
transgenic pHSTLuc lines (2D and 2E, both single copy) we
could not detect luciferase expression (not shown). Indeed,
pHSTLuc luciferase expression could be measured in a greater
number of tissues, as compared with pTLuc transgenic
animals.
Finally, all eight pLCRTLuc transgenic lines showed
luciferase expression, at variable levels, thereby rescuing the
weak activity of pTLuc reference construct in several tissues
(Fig. 3). The highest luciferase levels were measured in brain,
eyes, dorsal skin and skeletal muscle protein extracts. The
organs in which reporter expression was detected included
tyrosinase-expressing tissues (such as eyes and dorsal skin)
and tyrosinase-non-expressing tissues (such as brain and
skeletal muscle). Other organs analysed showed low reporter
expression, such as liver (Fig. 3) or very low reporter
expression, such as lung, thin gut, kidney and spleen (not
shown). None of these organs (with the exception of eyes and
dorsal skin) is known to contain tyrosinase-expressing cells.
No correlation was observed between transgene expression
levels and number of integrated copies within the host genome
with any of the transgenic constructs. Normalisation of
transgene expression data to copy number did not result in
comparable expression values per copy with any of the
transgenic constructs (not shown).
Analysis of LCR function: boundary activity measured
as protection from chromosomal position effects in
transgenic ¯ies
We decided to extend our analyses of mouse tyrosinase LCR
boundary activities, initiated in transgenic mice, using another
unrelated species, D.melanogaster, according to previous
studies performed with analogous vertebrate sequences
(29,36,61). Classically, boundary activities have been ana-
lysed in transgenic ¯ies. Therefore, we used the white
minigene assay to evaluate whether mouse tyrosinase LCR
sequences could insulate the expression of this reporter
construct, heavily in¯uenced by chromosomal position
effects, in ¯ies (28). The white minigene construct, if
ef®ciently protected from neighbouring chromatin, is ex-
pected to generate transgenic ¯ies with a yellow/pale-orange
eye colour. However, since P-element-mediated germ-line
transformation preferentially targets transgenes to open
chromatin regions, at the vicinity of endogenous promoters
and/or enhancers (64), unprotected white minigene constructs
will usually read these chromosomal position effects and
result in transgenic ¯ies with darker eye colour.
Figure 3. Analysis of boundary function of mouse tyrosinase LCR sequences in transgenic mice. Analysis of luciferase activity in transgenic mice generated
with pTLuc (four lines, 1A to 1D, white bars), pHSTLuc (three lines, 2A to 2C, grey bars) and pLCRTLuc (eight lines, 3A to 3H, black bars), as shown in
Figure 1D. Each bar represents the mean value of six adult individuals (6SD) in protein extracts from: eye (E), dorsal skin (S), skeletal muscle (M), brain
(B) and liver (L). Transgene copy number is indicated, in parentheses, for each line. Luciferase activity is expressed as relative light units (RLU) per
microgram of protein. Values that exceed this scale: (*) 979.52 6 196.3 and (**) 223.04 6 154.8 RLU/mg protein.
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Four experimental constructs were prepared carrying the
white minigene (51) `w' ¯anked at both ends by the HS, X,
LCR and LCRmut fragments (Fig. 1E). Two additional
constructs, BRwBR and 5¢HS4w5¢HS4, (Fig. 1E) were
included as experimental controls, containing previously
well-characterised boundary elements from D.melanogaster
(BR: Binding Region) of the Su(Hw) protein from the
gypsy retrotransposon element (35,52), and vertebrates
Figure 4. Analysis of boundary function of mouse tyrosinase LCR sequences in transgenic D.melanogaster. Protection from chromosomal position effects of
mouse tyrosinase LCR sequences was carried out in transgenic ¯ies using the white minigene assay. Top, ¯y heads, from reference white mutant stock along
with representative transgenic individuals for yellow, pale orange, orange, brown and red eye colours are shown. Pictures are taken in air from anaesthetised
animals. Percentage of red-pigment in eyes from each category, established by colorimetric methods (57), is indicated (100% = wild-type ¯ies). The average
amount of red-eye pigment within each line was estimated taking into account the percentage of individuals from a given colour observed within each line.
Mean values of red-pigment content in eyes for each independent transgenic line are depicted graphically as single bars using a logarithm scale (y axis),
because most of the perceived eye colour variability takes place below 10% of wild-type pigment level. Phenotypic evaluation of transgenic ¯ies is shown in
heterozygous (grey bars) and homozygous (black bars) individuals. A total of 86 transgenic ¯y lines are shown, grouped per construct and distributed as
follows: 14 lines for `w' (A and B); 11 for BRwBR (C and D); 11 for 5¢HS4w5¢HS4 (E and F); 13 for TE3wTE3 (G and H); 7 for XwX (I and J); 8 for
HSwHS (K and L); 12 for LCRwLCR (M and N); and 10 for LCRmutwLCRmut (O and P). In addition, the overall means and standard deviations (SD) for
all lines analysed within each construct are depicted as white bars and are also presented, without logarithm transformations, in Table 1.
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Figure 5. Genomic structure and chromatin analysis of DNA sequences surrounding the mouse tyrosinase LCR. (A) Schematic view of the genomic DNA
sequence (13 806 bp, GenBank AF364302) containing mouse tyrosinase LCR and neighbouring regions. All restriction enzyme sites for EcoRI (E), StyI (Y),
XbaI (A), XhoI (X) and SmaI (M) are shown. Below, the relative distance from the transcription start of tyrosinase gene is indicated in
kilobases (nucleotide positions according to Ensembl Project, Mouse Genome Sequencing Consortium; http://www.ensembl.org/Mus_musculus/
geneview?gene=ENSMUSG00000004651; derived from BAC clone RP24-459G24 (EMBL accession number AC122517). These nucleotide coordinates have
been used to update the position of the 3.7 kb EcoRI fragment, described previously at ±12 kb (14,17), according to an original physical restriction site map
made from overlapping bacteriophage clones (53). AF364302 is entirely contained within AC122517). A LINE1 element, located at 5¢ end of the sequence, is
indicated with a thick arrow. Relative position of DNA sub-fragments L1, LCR, HS and X, used for in vivo and in vitro expression analyses, are shown,
along with a CG-rich sequence similar to a CpG island (grey horizontal oval), a short G-rich sequence (grey vertical oval) and A-B boxes (grey squares). E3,
A, B, C, D and E5 DNA sub-fragments used as single-copy probes in DNase I sensitivity assays (grey boxes) and L1 and E6 repetitive DNA probes (striped
boxes) are displayed below as eight adjacent boxes aligned with the sequence map. (B) Repeated elements identi®ed in this sequence by Repeat Masker
(A.F.A.Smit and P.Green, unpublished work; http://ftp.genome.washington.edu/cgi-bin/RepeatMasker/) and displayed using PIPMaker symbols (95; http://
bio.cse.psu.edu/pipmaker/). Light grey boxes correspond to LINE1-related repeated sequences. Smaller repeats from other families are shown. (C) Percentage
of G + C plot along this sequence, using a window size of 30 nucleotides, generated with MacVector (Accelrys). DNA regions rich in G + C content that
coincide with the GC-rich stretch of DNA similar to a CpG island, the G-rich and AB the sequences are indicated with arrows. (D) Linear map showing the
occurrence of CpG dinucleotides (vertical bars) along this sequence. (E) Bisulphite genomic DNA sequencing of the 5¢ CG-rich stretch of DNA similar to a
CpG island in mouse melanoma B16 (above) and ®broblasts L929 (below) cells. The position of an EcoRI site, at 3¢ end (within a circle), is provided for
orientation purposes (AF364302, nucleotide position 5258). The relative positions of in vivo methylated CmpGs and unmethylated CpGs are shown as black
and open circles, respectively. (F) Representative DNase I sensitivity analysis with E3, A, B, C, D, E5 (described above) and PGK probes. Nuclear chromatin
samples obtained from melanoma B16 (black circles, thick line) and ®broblasts L929 (open circles, thin line) were digested with increasing amounts of
DNase I. Thereafter, equivalent amounts of puri®ed digested DNAs were spotted on nylon slot blots and hybridised with the indicated probe. Autoradiograms
were quantitated by PhosphorImage analysis and expressed as a percentage of hybridisation signal detected in the undigested DNA sample (assigned to
100%). These percentages are depicted in these seven graphs as a function of DNase I concentration (U.). Fifty per cent hybridisation of samples is indicated
with a dashed line. The estimated amount of DNase I required for 50% hybridisation is shown by descending dashed arrows. PGK probe is used as a control
and stands for the mouse phosphoglycerate kinase gene promoter, obtained from plasmid pHM2 (GenBank X76683, nucleotides 6557±7064). DNase I general
sensitivity assays were repeated three times with comparable results (in general, observed values varied between 5 and 20%, not shown).
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[5¢HS4: 5¢ DNase I hypersensitive number 4 from the chicken
b-globin locus (36)]. An unrelated DNA fragment from the
mouse tyrosinase locus, containing exon 3 and surrounding
intronic sequences was included as a negative control
(TE3wTE3; Fig. 1E). For this experiment, in contrast to the
experimental design devised for transgenic mice, the boundary
elements were cloned at either side of the white minigene
constructs since we reasoned that standard Drosophila
transgenesis, mediated by P-elements, usually proceeds
through single-copy integration of constructs (55).
Transgenic ¯ies were obtained for all constructs in a white
mutant genetic background. Single-copy lines that could be
established and evaluated both in heterozygosity and homo-
zygosity were subsequently chosen for phenotypic analysis
(Fig. 4). In general, and as expected, the phenotype of
homozygous transgenic ¯ies was stronger than their corres-
ponding heterozygous individuals from which they originate
(36). Therefore, we made use of homozygous individuals in
order to reveal presence/absence of boundary activities that
could not be easily detected in the corresponding heterozygous
animals.
Transgenic ¯ies carrying the white minigene `w' reference
construct clearly exhibited chromosomal position effects in
heterozygosity and homozygosity, resulting in heavily pig-
mented transgenic lines (bars with high values) and high
variability of pigmentation between independent lines (Fig. 4A
and B). No position effects were seen in ¯ies carrying the
positive control construct BRwBR, resulting in lines with
reduced eye pigment (bars with low values) and low
variability of pigmentation between independent lines
(Fig. 4C and D). The vertebrate positive control, construct
5¢HS4w5¢HS4, behaved differently. In heterozygous ¯ies
nearly all but one line showed weak eye colours, suggesting
an effective protection from chromosomal position effects, as
reported (36) (Fig. 4E). However, homozygous individuals
carrying this construct displayed stronger eye colour.
Additionally, there was a greater degree of variation in eye
colour between independent transgenic lines (Fig. 4F). The
pattern observed with transgenic ¯ies carrying the construct
5¢HS4w5¢HS4 was similar to that obtained with the ¯ies
carrying the TE3wTE3 negative control construct (Fig. 4G
and H), which did not show protection from position effects,
best seen in homozygous individuals (Fig. 4H).
All four experimental constructs containing different frag-
ments of the mouse tyrosinase LCR sequences: XwX,
HSwHS, LCRwLCR and LCRmutwLCRmut showed low
eye colour values in heterozygousity (Fig. 4I, K, M and O),
although the XwX lines showed the highest variability
(Fig. 4I). Corresponding homozygous individuals for
HSwHS (Fig. 4L) and LCRwLCR (Fig. 4N) maintained low
eye colour values and limited variability, suggesting an
effective protection from chromosomal position effects,
reproducing a pattern seen in BRwBR transgenic lines
(Fig. 4C and D). In contrast, XwX and LCRmutwLCRmut
homozygous ¯ies increased their eye colour values and
variability (Fig. 4J and P), indicating a reduced protection
from chromosomal position effects.
In summary, bona ®de boundary activity corresponded to
low means and reduced standard deviations of red-pigment
content in eyes (seen with BRwBR, HSwHS, LCRwLCR
constructs in heterozygosity and homozygosity, and with
LCRmutwLCRmut construct in heterozygosity). In contrast,
prevalence of chromosomal position effects correlated
with higher values for both means and standard devia-
tions (seen with w, 5¢HS4w5¢HS4, TE3wTE3, XwX con-
structs in heterozygosity and homozygosity and with
LCRmutwLCRmut construct in homozygosity) (Table 1).
Statistical evaluation of all transgenic ¯ies analysed, using the
hierarchical log-linear model, supported these observations
(see Supplementary Material).
Genomic and chromatin structure of DNA sequences
surrounding the mouse tyrosinase LCR
The presence of a new boundary activity within the mouse
tyrosinase LCR, as deduced from experiments in mice and
¯ies, prompted us to investigate the structure of the DNA
sequences surrounding these far-upstream 5¢ mouse tyrosinase
gene regulatory elements since genomic information was not
available in public databases. A bacteriophage clone, lT1,
carrying a 14 kb DNA insert including the mouse LCR
tyrosinase and neighbouring sequences, was isolated from a
mouse genomic library and sequenced (Fig. 5A).
Computer analysis of this genomic sequence indicated an
unusually large number of restriction sites cutting in G + C
rich sequences (i.e. SmaI, XhoI) and a high content of CpG
nucleotide residues located about 1 kb upstream of the 3.7 kb
EcoRI LCR fragment. This CG-rich stretch of DNA suggested
the presence of a CpG island, an element often associated with
promoters (65) (Fig. 5A). Comparisons of this sequence to
GenBank Database did not reveal homology with any known




% red-pigment in eyes
(mean 6 SD)
Homozygous individuals
% red-pigment in eyes
(mean 6 SD)
w 14 23.92 6 37.28 54.32 6 37.59
BRwBR 11 4.54 6 1.96 8.89 6 1.98
5¢HS4w5¢HS4 11 6.17 6 8.84 28.11 6 30.48
TE3wTE3 13 5.70 6 7.09 24.51 6 28.24
HSwHS 8 2.79 6 1.37 5.53 6 2.75
XwX 7 6.14 6 6.00 26.77 6 36.18
LCRwLCR 12 3.32 6 1.13 7.26 6 6.92
LCRmutwLCRmut 10 4.80 6 1.67 25.71 6 35.72
Percentage of red-pigment in eyes (referred to 100% = wild-type).
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gene. However, 5 kb from the 5¢ end of this 14 kb sequence
exhibited an almost perfect homology (98.4%) to a LINE1
element (GenBank M13002) (66), a member of a retro-
transposon-like family of highly repeated DNA sequences
(67). This LINE1 element is oriented in opposite direction,
with respect to the tyrosinase gene. Additional 3¢ sequences
were absent in the isolated genomic clone, but this LINE1
element is presumably complete in the mouse genome
(Fig. 5A). Further LINE1-related and other repeated DNA
sequences were detected within this 14 kb genomic fragment
(Fig. 5B).
The overall G + C content of the entire genomic sequence is
37.3%. However, there are several regions with a G + C
content exceeding 60%, including the CG-rich stretch of DNA
similar to a CpG island located 5¢ of the LINE1 element, the A
and B boxes, and a short G-rich sequence newly identi®ed at
the 5¢ end of the LCR (Fig. 5C).
Up to 79 occurrences of CpG dinucleotides were found in
the entire genomic sequence. The accumulation of CpG
residues was particularly high in the CG-rich stretch of DNA
similar to a CpG-island that maps at the 5¢ end of the LINE1
element and that contains its promoter sequences (Fig. 5D)
(66,67).
We reasoned that the presence of this promoter could
interfere with the regulation of tyrosinase gene expression. To
test this possibility we evaluated the LINE1 promoter activity
in vitro, in transient transfection assays using luciferase
reporter constructs. Results obtained suggested a poorly or
non-functional promoter function in mouse ®broblasts L929 or
B16 melanoma cells (see Supplementary Material).
In addition, we hypothesised that the LINE1 promoter
sequence could be methylated in vivo, further impairing
promoter function. To analyse this possibility we investigated
the methylation status of the CG-rich stretch of DNA similar
to a CpG island in vivo, in the tyrosinase locus of B16 and
L929 cells, applying bisulphite genomic sequencing protocols
(60) (Fig. 5E). All 15 CpG dinucleotides extending over the
CG-rich stretch of DNA of the LINE1 element were found
methylated in B16 cells. Comparably, all but one CpG
dinucleotides were also found methylated in L929 cells,
suggesting that this CG-rich stretch of DNA similar to a CpG
island was heavily methylated in both expressing and non-
expressing tyrosinase cells (Fig. 5E).
The methylation status of the LINE1 5¢ adjacent LCR
sequences suggested a closed chromatin structure in that area.
However, previous analysis had showed DNase I hypersen-
sitivity sites at the LCR-core, indicative of an open chromatin
structure (14). Thus, we decided to evaluate the chromatin
structure of LCR surrounding sequences. In this regard, we
performed DNase I sensitivity assays (61) over the LCR
region, in nuclei prepared from B16 and L929 cells, using six
Southern blot validated single-copy DNA consecutive probes
(E3, A, B, C, D, E5 fragments; Fig. 5A and F). Neighbouring
L1 and E6 fragments were excluded from this analysis
because they were experimentally shown to contain repeated
sequences. Additionally, an unrelated DNA probe (a fragment
containing the promoter of the ubiquitous mouse phosphogly-
cerate kinase gene; PGK, Fig. 5F) was included as a control
for the DNase I sensitivity assay. The amount of DNase I
required for 50% loss of hybridisation for each probe was
estimated from experimental data and compared between the
two considered cell types (Fig. 5F). Similar amounts of DNase
I were required for both cell types in the PGK control probe,
suggesting a comparable chromatin structure of this gene,
which is transcribed in these two cells. In contrast, for A, B, C
and D LCR-internal probes, there was a much higher
difference (up to more than two-times, for probe B) in
DNase I sensitivity between both cell types, suggesting that
chromatin over the LCR-core (probe D), and its surrounding
area (probes A, B and C), was more accessible in B16 cells,
where tyrosinase gene is transcribed, than it was in L929 cells,
where tyrosinase gene is not expressed. Outside the LCR area,
differences in DNase I sensitivity became smaller (probes E3
and E5), suggesting more similar chromatin structures in both
cell types.
Analysis of LCR function: evaluation of boundary
activities by transient transfection analysis in
mammalian cells
The results obtained in vivo (in transgenic mice and ¯ies) and
in vitro (methylation pattern of 5¢ LCR sequences and
chromatin structure over this area) pointed to the existence
of an additional boundary element within the mouse tyrosinase
LCR. Boundaries can be identi®ed in vivo by barrier or
enhancer-blocking assays (24,36,52). However, preliminary
information can be derived, in vitro, from transient transfec-
tion analysis in mammalian cells, as it has been shown before
(37,61).
In this regard, we set up to analyse the behaviour of new
constructs in transient transfection analysis in B16 and L929
cells. In these constructs, the entire LCR fragment and a series
of deletion derivatives were cloned, in either direction, in the
reference vector pTKLuc (Fig. 6). In B16 cells, plasmids
pHSTKLuc and pLCRTKLuc resulted in comparable
transactivation values (P = 0.509). Deletion of the AB boxes
completely abolished the enhancer capacity of the entire
LCR fragment (shown with pLCRDABTKLuc and
pRCLDABTKLuc; Fig. 6), as it has been shown before with
the HS fragment (Fig. 2F). Inversion of the LCR fragment
resulted in a statistical signi®cant ~41% reduction in
transactivation value (shown with pRCLTKLuc as compared
to pLCRTKLuc, P = 0.019), further supporting the existence
of boundary elements located 5¢ from the LCR-core (AB
boxes) (Fig. 6). Visual inspection of LCR surrounding
sequences had revealed a G-rich stretch at the 5¢ end
(Fig. 5A and C). We decided to test whether this short
sequence could contribute to establish a boundary, according
to informatic predictions (TRANSFAC Database) (68), which
suggested potential binding of zinc-®nger proteins, a family of
transcription factors that includes members described to bind
to insulators (38,61,69,70). Upon deletion of the G-rich short
sequence, construct pLCRDGTKLuc displayed comparable
transactivation value as that of its reference pLCRTKLuc (P =
0.393). In contrast, inversion of the LCR fragment carrying the
deletion of the G-rich sequence (construct pRCLDGTKLuc)
showed an intermediate transactivation value, both statistic-
ally signi®cant with respect to pLCRTKLuc (P = 0.042) and
pRCLTKLuc (P = 0.006). These results suggested that this
G-rich sequence could contribute, along with other neighbour-
ing sequences, to the boundary effect observed within the 5¢
LCR region. The inversion of the HS fragment resulted
in different transactivation values (~25%), statistically
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signi®cant between pHSTKLuc and pSHTKLuc (P = 0.010),
suggesting the putative existence of additional, although
minor, regulatory elements yet to be characterised. Similar
trend had been observed before with these two constructs
(Fig. 2E), although the higher variability obtained in that
experiment prevented statistical signi®cance of those observed
differences. Finally, the combined deletion of the G-rich
sequence and the AB boxes in pLCRDABGTKLuc and
pRCLDABGTKLuc constructs behaved similarly as the
deletion of AB boxes alone (Fig. 6). All these constructs
were also transfected in L929 cells, as a negative control,
resulting, as expected, in the absence of transactivation.
DISCUSSION
The mouse tyrosinase gene is associated with an LCR element,
located 15 kb from its promoter (17). To gain insight into the
activities present within this LCR, we have dissected and
studied enhancer and boundary functions in vitro and in vivo.
An internal fragment of the mouse tyrosinase LCR incorp-
orating the DNase I HS core (HS fragment) is able to
transactivate heterologous promoters in a cell-speci®c and
orientation-independent manner. The enhancer function of the
HS fragment was observed in all cell types analysed that
primarily express tyrosinase (melanocytes and RPE cells;
Fig. 2). Additionally, this enhancer function required the
presence of both boxes A and B, target sites for nuclear factors
that appear to bind members of the ubiquitous transcription
factors AP-1 and CREB protein families (14). The fact that a
cell-speci®c enhancer (associated with a cell-speci®c DNase I
HS) could be bound, apparently, by ubiquitous transcription
factors can be explained by considering the existence of
tissue-speci®c modi®cations of those ubiquitous transcription
factors, as discussed before (14). Our results extended
previous analyses of HS done in combination with the
endogenous tyrosinase promoter (14), suggesting the useful-
ness of tyrosinase enhancer modules with heterologous
promoters in gene transfer experiments. Similar results had
been obtained with the LCR element from the human b-globin
locus (71).
The relevance of A and B boxes in LCR function has been
studied in mice (50), using YAC-tyrosinase constructs with
analogous deletion-type experiments as those reported here in
transiently transfected cells. Transgenic mice obtained with
tyrosinase YACs carrying deletions in either box A or B, or
both, display more pigmentation than YAC-tyrosinase trans-
genic animals in which LCR had been deleted (10; P.Giraldo,
A.Lavado, M.Nadal and L.Montoliu, unpublished work).
These observations, the opposite of what we described
in vitro, prompted us to investigate the existence of additional
regulatory elements within the LCR regulatory region that
could compensate in vivo for the absence of A and B
sequences and contribute to establish a proper boundary for
this expression domain. In this regard, we evaluated whether
LCR tyrosinase sequences could counteract chromosomal
position effects on heterologous reporter constructs assayed in
transgenic animals, as one of the tests classically described to
assay for boundaries.
In transgenic mice, the addition of the entire mouse
tyrosinase LCR fragment (pLCRTLuc) to a poorly expressed
reporter construct prone to position effects (pTLuc) resulted in
elevated luciferase expression, at variable levels, in a variety
of organs containing or not tyrosinase-expressing cells, in all
lines (eight) analysed (Fig. 3). The smaller HS fragment
enhanced but did not guarantee expression of this reference
transgenic construct, as two out of ®ve pHSTLuc lines,
carrying single-copy transgenes, were silent. In this case, we
reasoned that the absence of LCR fragments inserted 3¢ of the
TLuc reporter construct could be a possible explanation for the
observed results. The other three lines showed variable
expression levels but in a larger number of organs, as
compared with pTLuc animals (Fig. 3). Results with
pLCRTLuc mice enhanced and extended the pHSTLuc
expression pattern due to the presence of tissue-speci®c
enhancers (AB boxes) and other boundary elements, presum-
ably located outside the HS region, at the 5¢ end of the LCR
fragment, that could be responsible for the expression rescue
of the reporter transgene, although at variable levels, in organs
which do not contain tyrosinase-expressing cells (i.e. brain).
These analyses extended previous observations in transgenic
mice, using the LCR fragment with its endogenous tyrosinase
promoter, in which only tissue-speci®c enhancer copy
Figure 6. Evaluation of boundary activities associated with tyrosinase LCR
sequences by transient transfection analysis in mammalian cells. Transient
transfection of backbone promoter-only plasmid pTKLuc, and its derivative
constructs: pHSTKLuc, pSHTKLuc, pLCRTKLuc, pRCLTKLuc,
pLCRDGTKLuc, pRCLDGTKLuc, pLCRDABTKLuc, pRCLDABTKLuc,
pLCRDABGTKLuc, pRCLDABGTKLuc in B16 (black bars) and L929
(white bars) cells. Schemes of these plasmids (left) and the result of
transfection in B16 and L929 cells (right) are shown. The AB enhancer-core
and G-rich sequences are depicted as black boxes. Grey or white boxes
correspond to the DNA fragments present or absent, respectively, in each
construct. The arrow depicted inside each DNA fragment represent the 5¢ to
3¢ direction, with respect to the position of these sequences within the
endogenous tyrosinase LCR and gene. Crossed and dashed lines indicate the
inversion of the same DNA fragment in their corresponding experimental
constructs. Results are expressed as relative transactivation, arbitrarily
assigning to the backbone plasmid pTKLuc the value of x1 and thereafter
referring the activity of each experimental construct to that value.
Normalisation of the luciferase reporter values between different transfected
constructs is achieved taking into account the activity of a co-transfected
lacZ reporter plasmid and the number of pmols of experimental plasmid
DNA used in each transfection. See Materials and Methods for plasmid
sizes. Relative transactivations are mean values from triplicate experiments
(6SD).
6300 Nucleic Acids Research, 2003, Vol. 31, No. 21
number-related effects were recorded (14). In addition, new
experiments are being undertaken to further evaluate the
boundary function of these sequences in vivo in combination
with other type of reporter constructs with a clearer tissue-
speci®c expression pattern, in contrast to the pattern observed
with pTLuc, which may not be expressed because of the
weakness of the promoter and/or the possibility that pTLuc
transgenes did not integrate nearby active enhancers.
There was no correlation between the level of the pHSTLuc
or pLCRTLuc transgene expression and their copy number.
We did not fully reproduce previous observations made when
the LCR fragment was fused to 5.5 kb of tyrosinase promoter
sequences in tyrosinase minigene constructs analysed in
transgenic mice (14), where copy number-related expression
was reported, suggesting that the behaviour of the LCR
fragment might be different in homologous (tyrosinase
minigene constructs) or heterologous (the pTLuc constructs
analysed here) environments. In fact, our results would
suggest that full LCR activity could only be achieved in a
`proper' genomic context, as in the case of YAC-tyrosinase
transgenes (11,17), where other regulatory elements are
present. Among them, the 5.5 kb proximal tyrosinase promoter
sequences [including binding sites for microphthalmia (Mitf),
a key transcriptional regulator of the tyrosinase locus (72,73)]
that were also present in previous tyrosinase minigene
constructs (14).
The same lack of correlation has been reported using
boundary elements from other expression domains in com-
bination with heterologous promoters (43,44 but see updated
results in 42,74±76). However, the inclusion of boundary
elements in gene transfer experiments, such as those reported
here, normally increases the probability of expression of
transgenes and therefore their use in heterologous constructs is
recognised as potentially bene®cial (5,7,12,77,78). Indeed, the
5¢HS4 boundary element greatly enhances the number of
mouse lines expressing the transgenes, irrespectively of the
promoter, but it is de®nitely unable to prevent totally
variegation and it does not allow copy number-dependent
expression (Louis-Marie Houdebine, personal communica-
tion). Similarly, with our tyrosinase LCR elements, ef®cient
protection from chromosomal position effects could not be
revealed in transgenic mice, since copy number-dependent
and position-independent expression of a poorly expressed
reporter construct was not guaranteed. Instead, the elevated
general expression observed pointed to the existence of
boundary elements within the 5¢ upstream regulatory region of
the tyrosinase gene that would possibly operate in a tissue-
unrelated manner. In addition, the lack of copy number-
dependent expression can also be explained, in transgenic
lines with high copy numbers as a potential result of
heterochromatin-mediated silencing induced by transgene
repeats, as initially reported in Drosophila (79). Copy
number-dependent expression is a property usually associated
with the presence of functional LCR elements (17,19±21) that
may not necessarily be associated with functional boundary
elements. Indeed, complex higher-order regulatory elements,
such as possibly the mouse tyrosinase LCR genomic region,
shown to contain a functional LCR (11,14,17) plus additional
putative boundary elements (this manuscript), suggest that
several activities from multiple composite elements may
co-exist and contribute to specify a given eukaryotic expres-
sion domain.
To con®rm and extend our barrier function analyses of
mouse tyrosinase LCR sequences we decided to perform these
assays in a more suitable but heterologous species,
D.melanogaster, where boundary activities have been
classically reported (29,36,61) (Fig. 4).
In transgenic ¯ies, tyrosinase LCR-derived sequences
(constructs HSwHS and LCRwLCR) ef®ciently protected a
white minigene construct from chromosomal position effects,
both in heterozygous and homozygous animals, to a degree
that compared favourably with a well-established
D.melanogaster insulator (BR), from the gypsy retrotranspo-
son element (35,52). A similar behaviour was observed with
the LCRmutwLCRmut construct, in heterozygous animals.
Furthermore, in these experiments, mouse tyrosinase LCR-
derived sequences displayed better insulating capacities over
chromosomal position effects compared with the reference
vertebrate insulator (5¢HS4), that behaved differently from
what had been reported previously with fewer number of lines
analysed and two copies of the 5¢HS4 insulator element at
either side of white minigene constructs (36). The boundary
effect of mouse tyrosinase LCR sequences observed in ¯ies
appeared to correlate primarily with its LCR-core, since
XwX (in heterozygous and homozygous ¯ies) and
LCRmutwLCRmut (in homozygous ¯ies) constructs did not
reproduce the pattern observed with HSwHS and LCRwLCR
constructs. In ¯ies, the LCR-core (HS fragment) appears to be
necessary and suf®cient for boundary activity, whereas in
mice, the same HS fragment seems to be necessary but not
suf®cient. This suggests that, in mice, sequences 5¢ to the
LCR-core also contribute to barrier function. A number of
reasons could account for the different behaviour of the LCR
fragment in mice and ¯ies, including that proteins associated
to 5¢ LCR sequences in mice are not functional or even not
present in ¯ies. Furthermore, we cannot rule out that there is a
fundamental difference in boundary activity in Drosophila
as compared with mice, as indicated by differences in
the behaviour of 5¢HS4w5¢HS4, TE3wTE3 and
LCRmutwLCRmut constructs in heterozygosity and homo-
zygosity. Other phenomena, such as transvection (80), could
also be in¯uencing the results obtained in homozygous
individuals, as discussed before for the analysis of the 5¢HS4
boundary element of the chicken b-globin locus in transgenic
¯ies (36).
In this study, we used TE3wTE3 as a negative control,
instead of using prokaryotic DNA (28,36,57), reasoning that
unrelated sequences from the same locus would better control
for unspeci®c barrier activity, as reported previously (29).
Indeed, the TE3wTE3 construct behaved similarly as `w' and
5¢HS4w5¢HS4 constructs in heterozygous and homozygous
individuals, supporting the absence of insulating activities in
this negative control (Fig. 4, Table 1 and Supplementary
Material).
The presence of boundary activities within the mouse
tyrosinase LCR had been indirectly addressed during the
analysis of standard-type tyrosinase transgenic mice. Indeed,
the addition of the entire LCR fragment enhanced the
expression of minigene tyrosinase constructs in transgenic
mice (14,16). Porter and colleagues demonstrated, in some
lines, increased tyrosinase expression by adding the 5¢ end of
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the LCR (15) or the LCR-core alone (16), also indicating the
existence of additional regulatory elements in that area. Those
results were explained as a product of S/MAR activities,
identi®ed previously within the LCR (13). However, we have
failed to con®rm signi®cant S/MAR activity in the LCR using
in vitro comparable experiments and sequence-based S/MAR
predictions (not shown). This would not be the ®rst case in
which a LCR has been found to be devoid of S/MAR activities
(81). Indeed, the implication of enhancers, such as the LCR-
core, in the establishment of boundaries, acting as chromatin
openers has been proposed as an alternative model to
understand insulator function (45). Also, classical insulators
have been reported recently to function as transcriptional
stimulators (24) and, on the other hand, transcriptional
activators have also recently been shown to insulate active
loci against chromatin repression (82). In this regard, our data
would support the notion that strong enhancers might have
been recruited during evolution to contribute to establish
boundaries.
Our experiments in ¯ies suggested that most of the
boundary activity present within the mouse tyrosinase LCR
was associated with its core enhancer (HS fragment).
However, we decided to investigate the possible existence of
additional boundary elements, outside the enhancer, that could
explain why the entire LCR fragment behaved differently than
the HS fragment in transgenic mice. In this regard, we
sequenced 14 kb of genomic DNA surrounding the mouse
tyrosinase LCR, thereby completing 5¢ upstream LCR
sequences that were absent in public databases. The analysis
of this genomic sequence identi®ed an apparently entire
LINE1 element, containing a CG-rich stretch of DNA similar
to a CpG island, located upstream of the LCR fragment, and
oriented in opposite direction with respect to the tyrosinase
gene (Fig. 5A). In fact, the presence of LINE1-derived
sequences appears to be a characteristic feature of the mouse
tyrosinase locus (L.Regales, P.Giraldo, A.Lavado and
L.Montoliu, in preparation), and it might have played a role
in the generation of some tyrosinase mutant alleles (such as
chinchilla-mottled mice, Tyrc±m) (13).
LINE1 sequences are retrotransposon-related repeated
DNA elements, 6±7 kb long, carrying two open-reading
frames and found in high numbers (~104±105) in the mouse
genome (67,83). Most of these elements (>90%) appear to be
truncated in its 5¢ end, thereby resulting in inactive copies.
LINE1 elements have been associated with the regulation of
several mammalian loci and have been proposed to contribute
to genomic evolution and mutation (83). In this sense, the
transcriptional abilities of LINE1 elements have been correl-
ated with their capacity to induce epigenetic phenomena, due
to their potential to interfere with normal transcription of
neighbouring genes (84,85).
We investigated whether the LINE1 element located 5¢
upstream of the mouse tyrosinase LCR was functional and if it
could in¯uence tyrosinase expression. Our ®ndings in vitro
indicated that the promoter of this LINE1 element (a CG-rich
stretch of DNA similar to a CpG-island) is practically silent in
transfection assays (see Supplementary Material). Indeed, we
have found that this CG-rich stretch of DNA similar to a CpG
island is heavily methylated in vivo, in these two cell types
(Fig. 5E). It has been proposed that DNA methylation at
promoters of repeated elements could represent a defence
mechanism to inactivate their transcription and prevent their
mobilisation to ectopic genomic locations (86). Further, DNA
methylation has been associated with histone deacetylation
(87), and corresponding chromatin condensation (88), that can
in turn result in the silencing of transcription (89). Thus, the
presence of a heavily methylated LINE1 element next to the
tyrosinase LCR could represent a potential danger if the
spreading of DNA condensation would reach the LCR-core.
We have shown experimentally, using DNase I sensitivity
assays (61), that chromatin surrounding the LCR region is
more accessible to DNase I digestion in B16 cells, as
compared with L929 cells (Fig. 5F). Differences in DNase I
sensitivity extended well beyond the LCR-core in its 5¢ region,
up to the LINE1 element, suggesting that these sequences
upstream of the LCR-core could contribute in establishing a
boundary. Therefore, our data would support the existence of a
regulatory element between the CG-rich stretch of DNA
similar to a CpG-island of the LINE1 element and the LCR-
core, with properties of a barrier, capable of preventing
potential interferences of upstream genomic sequences with
LCR function. Similar barrier functions have been associated
with the 5¢HS4 insulator from the chicken b-globin locus,
coupling high histone acetylation levels and protecting DNA
from methylation (90).
To reveal the presence of such additional boundary
elements in the 5¢ LCR region we decided to evaluate its
potential enhancer-blocking capacity, in vitro, using transient
transfection into mammalian cells, as reported before (37,61).
These analyses ®rst showed that the entire LCR and the HS
fragments displayed comparable enhancer activities on a
heterologous reporter construct (pTKLuc; Fig. 6). This
enhancer activity was mostly dependent on the presence of
the AB boxes (Figs 2F and 6). Upon inversion of the LCR
fragment, the relative transactivation decreased in a signi®cant
manner. This ®nding suggested the existence of an additional
regulatory element, normally located 5¢ of the LCR-core,
which upon inversion and placement between the enhancer
and the promoter, could interfere with the transactivation
activity. Sequence inspection of the region between the LINE1
element and the LCR-core highlighted a short G-rich
sequence, at the 5¢ end of LCR (Fig. 5A and C). Informatic
predictions suggested that this sequence could bind transcrip-
tion factors belonging to the family of zinc-®nger nuclear
proteins (68). A member of this family, the multifunctional
nuclear protein CTCF has been shown to bind to a number of
insulator sequences (38,61,69), without an apparent consensus
in the target site other than the presence of several G-residues
(70). We will analyse the potential association of zinc-®nger
nuclear proteins with the short G-rich sequence found at the 5¢
end of LCR.
To evaluate the putative role of this short G-rich region we
prepared several deletion constructs derived from the entire
LCR fragment. As expected, the LCR fragment carrying a
deletion of the G-rich sequence (LCRDG), in its natural
orientation, retained the enhancer capacity of the entire
fragment (Fig. 6). The inversion of this fragment (RCLDG)
resulted again in a decreased enhancer capacity, as compared
with LCR and LCRDG. However, this decrease was different
and statistically signi®cant from the inversion of the entire
LCR (RCL construct), thus suggesting that both this G-rich
region plus other neighbouring sequences within the 5¢ region
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might be required for the observed enhancer-blocking effects.
The results obtained with the HS fragment, in its natural and
inverted direction (Fig. 6), do not rule out the existence of
additional elements within this fragment that will be studied in
subsequent experiments. Formally, we cannot exclude an
effect of the small differences in distance between the LCR-
core and the promoter in these reporter constructs (1 kb in
LCR and 2.7 kb in RCL). However, we think that this effect, if
present, would not have a major signi®cance since these
regulatory elements have been shown to operate in vivo at
different distances (from ~2 to ~15 kb) with comparable
ef®ciencies (14,16,17), and the relative transactivation of the
LCR-core (AB-boxes) to heterologous promoters is compar-
able with that of the LCR or the HS fragments (not shown). In
addition, at present, we cannot exclude that the enhancer
function mapping at the AB boxes could not transactivate the
heterologous promoter `around the clock', following the
circular DNA molecule transiently transfected. Indeed, this
might be a potential explanation for the limited enhancer-
blocking activity observed upon inverting the entire LCR
fragment. Moreover, conventional repressor activity could
also be responsible for the observed effects in transiently
transfected cells. The comparison of relative transactivaction
capacities of pRCLDABTKLuc and pRCLDABGTKLuc con-
structs (Fig. 6) could either be interpreted as a result of
boundary or repressor activities mapping at the G-rich
sequence. Forthcoming analyses will address the enhancer-
blocking capacities of elements found within the mouse
tyrosinase LCR in vivo, in transgenic ¯ies and mice, but also in
mammalian cells, where different type of constructs will be
prepared to discriminate between repressor and enhancer-
blocking activities.
Taken together, our results indicate the presence of a
putative new boundary activity in the mouse tyrosinase LCR.
Several elements can participate in this putative boundary
activity including known (i.e. the LCR-core or enhancer) and
newly described (i.e. the G-rich region and, possibly, other
sequences located 5¢ of the LCR-core) sequences. Future
experiments will establish the relative contribution of these
different elements in the observed barrier and enhancer-
blocking effects, as it has been described recently for the
chicken b-globin insulator (40).
In this work, we have analysed the putative boundary
properties of the 5¢ LCR element at either side of reporter
transgenic constructs, both in mice and ¯ies. However, this
element is only found at the 5¢ end of the mouse tyrosinase
gene in its native genomic location. Forthcoming analyses will
also investigate the presence of analogous sequences, sharing
similar boundary properties as those found at the 5¢ region of
the LCR, in the 3¢ region of the mouse tyrosinase gene, which
could potentially contribute to specify the mouse tyrosinase
expression domain.
The systematic description of new boundary elements in
different expression domains, such the tyrosinase locus, is
required to extend our still limited knowledge regarding the
function and mode-of-action of these sequences and how they
could contribute to insulate contiguous transcription units with
different expression patterns. However, the unexpected dis-
covery of ubiquitously expressed genes within previously
well-established tissue-speci®c expression domains, reported
in the case of the human a-globin (91), the human growth
hormone (92,93) and the chicken lysozyme (94) loci, would
argue that differentially expressed transcription units might
coexist within the same functional chromatin domain. In this
sense, it will be instrumental to study and reveal the in vivo
role of potential insulators/boundaries before attempting to
export their blocker/barrier abilities to ectopic locations in
gene transfer experiments. Failure to fully understand these
elements may be responsible for the limited success of
boundaries usually observed in transgenic experiments.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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